HB 788

  • Kentucky House Bill
  • 2025 Regular Session
  • Introduced in House Feb 19, 2025
  • House
  • Senate
  • Governor

AN ACT relating to buprenorphine products.

Abstract

Create a new section of KRS Chapter 311 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed physician to meet the treatment needs of a patient; require the Kentucky Board of Medical Licensure to promulgate administrative regulations to implement the requirement; create a new section of KRS Chapter 314 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed advanced practice registered nurse meet the treatment needs of a patient; require the Kentucky Board of Nursing to promulgate administrative regulations to implement the requirement.

Bill Sponsors (0)

Votes


No votes to display

Actions


Mar 05, 2025

House

taken from Health Services (H)

House

1st reading

House

returned to Health Services (H)

Feb 26, 2025

House

to Health Services (H)

Feb 19, 2025

House

introduced in House

House

to Committee on Committees (H)

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.